Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tivan Sciences is a California-based biotechnology company dedicated to the discovery and development of innovative small molecule therapeutics for oncology and autoimmune disorders. The company leverages its proprietary drug discovery platform to target complex biological pathways that have historically been difficult to modulate. By focusing on high-impact, challenging targets, Tivan Sciences aims to deliver transformative treatments for patients with limited therapeutic options. Currently in the pre-clinical stage, the company is building a pipeline of candidates designed to improve clinical outcomes in hard-to-treat cancers and inflammatory conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tivan Sciences.